PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma

BACKGROUND: The PD-1 receptor and its ligands PD-L1 and PD-L2 are known to be significantly involved in T-cell regulation. Recent studies suggest that PD-L1 expression in malignant tumors contributes to an immunosuppressive microenvironment and disruption of antitumoral immune response. Drugs target...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Müller, Tim, Braun, Martin, Dietrich, Dimo, Aktekin, Seher, Höft, Simon, Kristiansen, Glen, Göke, Friederike, Schröck, Andreas, Brägelmann, Johannes, Held, Stefanie A.E., Bootz, Friedrich, Brossart, Peter
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2017
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5581079/
https://ncbi.nlm.nih.gov/pubmed/28881780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17547
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы